Who has invested in Spine BioPharma?

Viscogliosi Bros., LLC are named among the investors backing Spine BioPharma.

Spine BioPharma Funding: $13M Raised, Series B (2022)

Spine BioPharma funding overview

Spine BioPharma is based in New York, NY. Spine BioPharma has raised $13M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Spine BioPharma runs through 2022; nothing later has been disclosed. Investors on record include Viscogliosi Bros., LLC.

Spine BioPharma at a glance

Total raised: $13M
Latest round: Series B
Latest round date: March 2022
Headquarters: New York, NY
Notable investors: Viscogliosi Bros., LLC

Frequently asked about Spine BioPharma funding

How much has Spine BioPharma raised?: Spine BioPharma has raised $13M in total disclosed funding across the rounds on record.
Who has invested in Spine BioPharma?: Viscogliosi Bros., LLC are named among the investors backing Spine BioPharma.
What was the latest Spine BioPharma funding round?: The most recent disclosed round is a Series B, announced in March 2022.
Where is Spine BioPharma based?: Spine BioPharma is based in New York, NY.
When did Spine BioPharma last raise?: The last disclosed Spine BioPharma round closed in March 2022 at Series B.

Spine BioPharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.

Spine BioPharma Funding: $13M Raised, Series B (2022)

Spine BioPharma funding overview

Spine BioPharma at a glance

Frequently asked about Spine BioPharma funding

Companies related to Spine BioPharma (18)

Browse related funding lists (5)